1. [Epidemiological profile of dermatomyositis and polymyositis: a study conducted in the Department of Rheumatology in Marrakech].
- Author
-
Errafia S, Mougui A, and Bouchti IE
- Subjects
- Adolescent, Adrenal Cortex Hormones administration & dosage, Adult, Aged, Biopsy, Dermatomyositis diagnosis, Dermatomyositis drug therapy, Edema epidemiology, Erythema epidemiology, Erythema etiology, Female, Heart Diseases epidemiology, Humans, Male, Middle Aged, Morocco, Myositis diagnosis, Myositis drug therapy, Neoplasms epidemiology, Polymyositis diagnosis, Polymyositis drug therapy, Retrospective Studies, Young Adult, Dermatomyositis epidemiology, Myositis epidemiology, Polymyositis epidemiology
- Abstract
Dermatomyositis (DM) and polymyositis (PM) are rare but serious conditions. The purpose of this study was to investigate, by a review of hospital cases, their epidemiological, clinical and evolutionary profile. We conducted a retrospective study over a 15-year period, between January 2004 and December 2019. All cases with possible or definite diagnosis according to Bohan and Peter's criteria were retained. A total of 14 patients were enrolled (8 DM and 6 PM), with an average age of 48.7 years. Sex ratio was 13F/ 1H. General signs were reported in 71% of cases. Motor deficit affected the girdle muscles in 71% of cases; 85.7% of patients had arthralgia and 14% arthritis. Erythema and periorbital edema were the predominant skin signs. Patients' assessment showed increased sedimentation rate in all cases and increased muscle enzymes in 80% of cases. Antinuclear antibodies were positive in 63% of cases. Muscle biopsy objectified inflammatory myositis in 75% of cases. Heart disease was reported in 14% of cases and lung disease in 21%. Cancer was found in 21.4% of cases. All patients received corticosteroid therapy. Improvement was reported in 88% of patients, with a relapse in 4 patients. In our context, DM is more frequent than PM, with a clear female predominance. Pulmonary disease is a heavy complication. Its association with cancers occurs commonly, hence the need for a systematic cancer screening at diagnosis and follow-up., Competing Interests: Les auteurs ne déclarent aucun conflit d´intérêts., (Copyright: Souhil Errafia et al.)
- Published
- 2021
- Full Text
- View/download PDF